MENÚ

Estudios clínicos e investigación

The pediatric endocrinology team at Arkansas Children's is actively involved in research to find the best treatments for diabetes and other pediatric endocrine conditions. Our doctors, nurses and other staff take part in local, national and global investigations of new and existing treatments. This means your child has access to the most advanced care available, including the chance to participate in clinical trials when appropriate.

We work with TrialNet, an international network of universities, medical centers and doctors, scientists and healthcare teams, to research and innovate ways to prevent Type 1 diabetes. TrialNet provides:

  • Risk screening for relatives of people with Type 1 diabetes
  • Clinical studies to preserve insulin production

Industry-Sponsored Studies

Investigator-Initiated Studies

Our doctors are preparing to launch multiple corporate studies that will expose our patients and families to more cutting-edge therapies. Incluyen:

  • Growth hormone studies. Michele Hutchison, MD, is leading several studies related to growth hormone deficiency and using growth hormone to treat endocrine conditions. Several doctors are
  • Type 2 diabetes. Michele Hutchison, MD, is leading several studies related to care and treatments for children with Type 2 diabetes.
  • Fatty liver disease. Emir Tas, MD, has received funding through the Arkansas Children’s Research Institute to study the relationship of FG-21 and fatty liver disease. The goal is to find ways to more closely and accurately monitor the disease process. Fatty liver disease is very common and considered a significant issue given it may be the leading cause of cirrhosis by 2030.